- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Botanical Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Botanical Drug market size is estimated to be worth US$ 33630 million in 2021 and is forecast to a readjusted size of USD 43740 million by 2028 with a CAGR of 3.8% during review period. Cardiovascular accounting for % of the Botanical Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prescription Drug segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Botanical Drug include Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, and Tong Ren Tang, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Botanical Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prescription Drug
OTC
Market segment by Application, can be divided into
Cardiovascular
Tumor
Respiratory System
Others
Market segment by players, this report covers
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Botanical Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Botanical Drug, with revenue, gross margin and global market share of Botanical Drug from 2019 to 2022.
Chapter 3, the Botanical Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Botanical Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Botanical Drug research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Botanical Drug
1.2 Classification of Botanical Drug by Type
1.2.1 Overview: Global Botanical Drug Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Botanical Drug Revenue Market Share by Type in 2021
1.2.3 Prescription Drug
1.2.4 OTC
1.3 Global Botanical Drug Market by Application
1.3.1 Overview: Global Botanical Drug Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Others
1.4 Global Botanical Drug Market Size & Forecast
1.5 Global Botanical Drug Market Size and Forecast by Region
1.5.1 Global Botanical Drug Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Botanical Drug Market Size by Region, (2017-2022)
1.5.3 North America Botanical Drug Market Size and Prospect (2017-2028)
1.5.4 Europe Botanical Drug Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Botanical Drug Market Size and Prospect (2017-2028)
1.5.6 South America Botanical Drug Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Botanical Drug Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Botanical Drug Market Drivers
1.6.2 Botanical Drug Market Restraints
1.6.3 Botanical Drug Trends Analysis
2 Company Profiles
2.1 Buchang Pharmaceuticals
2.1.1 Buchang Pharmaceuticals Details
2.1.2 Buchang Pharmaceuticals Major Business
2.1.3 Buchang Pharmaceuticals Botanical Drug Product and Solutions
2.1.4 Buchang Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Buchang Pharmaceuticals Recent Developments and Future Plans
2.2 China TCM
2.2.1 China TCM Details
2.2.2 China TCM Major Business
2.2.3 China TCM Botanical Drug Product and Solutions
2.2.4 China TCM Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 China TCM Recent Developments and Future Plans
2.3 Tsumura
2.3.1 Tsumura Details
2.3.2 Tsumura Major Business
2.3.3 Tsumura Botanical Drug Product and Solutions
2.3.4 Tsumura Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Tsumura Recent Developments and Future Plans
2.4 Schwabe
2.4.1 Schwabe Details
2.4.2 Schwabe Major Business
2.4.3 Schwabe Botanical Drug Product and Solutions
2.4.4 Schwabe Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Schwabe Recent Developments and Future Plans
2.5 Tong Ren Tang
2.5.1 Tong Ren Tang Details
2.5.2 Tong Ren Tang Major Business
2.5.3 Tong Ren Tang Botanical Drug Product and Solutions
2.5.4 Tong Ren Tang Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Tong Ren Tang Recent Developments and Future Plans
2.6 Jumpcan Pharmaceutical
2.6.1 Jumpcan Pharmaceutical Details
2.6.2 Jumpcan Pharmaceutical Major Business
2.6.3 Jumpcan Pharmaceutical Botanical Drug Product and Solutions
2.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Jumpcan Pharmaceutical Recent Developments and Future Plans
2.7 Guangzhou Baiyunshan Pharmaceutical
2.7.1 Guangzhou Baiyunshan Pharmaceutical Details
2.7.2 Guangzhou Baiyunshan Pharmaceutical Major Business
2.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Solutions
2.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments and Future Plans
2.8 Yunnan Baiyao
2.8.1 Yunnan Baiyao Details
2.8.2 Yunnan Baiyao Major Business
2.8.3 Yunnan Baiyao Botanical Drug Product and Solutions
2.8.4 Yunnan Baiyao Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Yunnan Baiyao Recent Developments and Future Plans
2.9 Tasly Holding Group
2.9.1 Tasly Holding Group Details
2.9.2 Tasly Holding Group Major Business
2.9.3 Tasly Holding Group Botanical Drug Product and Solutions
2.9.4 Tasly Holding Group Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Tasly Holding Group Recent Developments and Future Plans
2.10 Bionorica Se
2.10.1 Bionorica Se Details
2.10.2 Bionorica Se Major Business
2.10.3 Bionorica Se Botanical Drug Product and Solutions
2.10.4 Bionorica Se Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Bionorica Se Recent Developments and Future Plans
2.11 Huarun 999
2.11.1 Huarun 999 Details
2.11.2 Huarun 999 Major Business
2.11.3 Huarun 999 Botanical Drug Product and Solutions
2.11.4 Huarun 999 Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Huarun 999 Recent Developments and Future Plans
2.12 Taiji
2.12.1 Taiji Details
2.12.2 Taiji Major Business
2.12.3 Taiji Botanical Drug Product and Solutions
2.12.4 Taiji Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Taiji Recent Developments and Future Plans
2.13 Weleda
2.13.1 Weleda Details
2.13.2 Weleda Major Business
2.13.3 Weleda Botanical Drug Product and Solutions
2.13.4 Weleda Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Weleda Recent Developments and Future Plans
2.14 Kwangdong
2.14.1 Kwangdong Details
2.14.2 Kwangdong Major Business
2.14.3 Kwangdong Botanical Drug Product and Solutions
2.14.4 Kwangdong Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Kwangdong Recent Developments and Future Plans
2.15 GW Pharmaceuticals
2.15.1 GW Pharmaceuticals Details
2.15.2 GW Pharmaceuticals Major Business
2.15.3 GW Pharmaceuticals Botanical Drug Product and Solutions
2.15.4 GW Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 GW Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Botanical Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Botanical Drug Players Market Share in 2021
3.2.2 Top 10 Botanical Drug Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Botanical Drug Players Head Office, Products and Services Provided
3.4 Botanical Drug Mergers & Acquisitions
3.5 Botanical Drug New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Botanical Drug Revenue and Market Share by Type (2017-2022)
4.2 Global Botanical Drug Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Botanical Drug Revenue Market Share by Application (2017-2022)
5.2 Global Botanical Drug Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Botanical Drug Revenue by Type (2017-2028)
6.2 North America Botanical Drug Revenue by Application (2017-2028)
6.3 North America Botanical Drug Market Size by Country
6.3.1 North America Botanical Drug Revenue by Country (2017-2028)
6.3.2 United States Botanical Drug Market Size and Forecast (2017-2028)
6.3.3 Canada Botanical Drug Market Size and Forecast (2017-2028)
6.3.4 Mexico Botanical Drug Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Botanical Drug Revenue by Type (2017-2028)
7.2 Europe Botanical Drug Revenue by Application (2017-2028)
7.3 Europe Botanical Drug Market Size by Country
7.3.1 Europe Botanical Drug Revenue by Country (2017-2028)
7.3.2 Germany Botanical Drug Market Size and Forecast (2017-2028)
7.3.3 France Botanical Drug Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Botanical Drug Market Size and Forecast (2017-2028)
7.3.5 Russia Botanical Drug Market Size and Forecast (2017-2028)
7.3.6 Italy Botanical Drug Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Botanical Drug Revenue by Type (2017-2028)
8.2 Asia-Pacific Botanical Drug Revenue by Application (2017-2028)
8.3 Asia-Pacific Botanical Drug Market Size by Region
8.3.1 Asia-Pacific Botanical Drug Revenue by Region (2017-2028)
8.3.2 China Botanical Drug Market Size and Forecast (2017-2028)
8.3.3 Japan Botanical Drug Market Size and Forecast (2017-2028)
8.3.4 South Korea Botanical Drug Market Size and Forecast (2017-2028)
8.3.5 India Botanical Drug Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Botanical Drug Market Size and Forecast (2017-2028)
8.3.7 Australia Botanical Drug Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Botanical Drug Revenue by Type (2017-2028)
9.2 South America Botanical Drug Revenue by Application (2017-2028)
9.3 South America Botanical Drug Market Size by Country
9.3.1 South America Botanical Drug Revenue by Country (2017-2028)
9.3.2 Brazil Botanical Drug Market Size and Forecast (2017-2028)
9.3.3 Argentina Botanical Drug Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Botanical Drug Revenue by Type (2017-2028)
10.2 Middle East & Africa Botanical Drug Revenue by Application (2017-2028)
10.3 Middle East & Africa Botanical Drug Market Size by Country
10.3.1 Middle East & Africa Botanical Drug Revenue by Country (2017-2028)
10.3.2 Turkey Botanical Drug Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Botanical Drug Market Size and Forecast (2017-2028)
10.3.4 UAE Botanical Drug Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Botanical Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Botanical Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Botanical Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Botanical Drug Revenue (USD Million) by Region (2017-2022)
Table 5. Global Botanical Drug Revenue Market Share by Region (2023-2028)
Table 6. Buchang Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Buchang Pharmaceuticals Major Business
Table 8. Buchang Pharmaceuticals Botanical Drug Product and Solutions
Table 9. Buchang Pharmaceuticals Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. China TCM Corporate Information, Head Office, and Major Competitors
Table 11. China TCM Major Business
Table 12. China TCM Botanical Drug Product and Solutions
Table 13. China TCM Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Tsumura Corporate Information, Head Office, and Major Competitors
Table 15. Tsumura Major Business
Table 16. Tsumura Botanical Drug Product and Solutions
Table 17. Tsumura Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Schwabe Corporate Information, Head Office, and Major Competitors
Table 19. Schwabe Major Business
Table 20. Schwabe Botanical Drug Product and Solutions
Table 21. Schwabe Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Tong Ren Tang Corporate Information, Head Office, and Major Competitors
Table 23. Tong Ren Tang Major Business
Table 24. Tong Ren Tang Botanical Drug Product and Solutions
Table 25. Tong Ren Tang Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Jumpcan Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 27. Jumpcan Pharmaceutical Major Business
Table 28. Jumpcan Pharmaceutical Botanical Drug Product and Solutions
Table 29. Jumpcan Pharmaceutical Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Guangzhou Baiyunshan Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 31. Guangzhou Baiyunshan Pharmaceutical Major Business
Table 32. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Solutions
Table 33. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Yunnan Baiyao Corporate Information, Head Office, and Major Competitors
Table 35. Yunnan Baiyao Major Business
Table 36. Yunnan Baiyao Botanical Drug Product and Solutions
Table 37. Yunnan Baiyao Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Tasly Holding Group Corporate Information, Head Office, and Major Competitors
Table 39. Tasly Holding Group Major Business
Table 40. Tasly Holding Group Botanical Drug Product and Solutions
Table 41. Tasly Holding Group Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Bionorica Se Corporate Information, Head Office, and Major Competitors
Table 43. Bionorica Se Major Business
Table 44. Bionorica Se Botanical Drug Product and Solutions
Table 45. Bionorica Se Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Huarun 999 Corporate Information, Head Office, and Major Competitors
Table 47. Huarun 999 Major Business
Table 48. Huarun 999 Botanical Drug Product and Solutions
Table 49. Huarun 999 Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Taiji Corporate Information, Head Office, and Major Competitors
Table 51. Taiji Major Business
Table 52. Taiji Botanical Drug Product and Solutions
Table 53. Taiji Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Weleda Corporate Information, Head Office, and Major Competitors
Table 55. Weleda Major Business
Table 56. Weleda Botanical Drug Product and Solutions
Table 57. Weleda Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Kwangdong Corporate Information, Head Office, and Major Competitors
Table 59. Kwangdong Major Business
Table 60. Kwangdong Botanical Drug Product and Solutions
Table 61. Kwangdong Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. GW Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 63. GW Pharmaceuticals Major Business
Table 64. GW Pharmaceuticals Botanical Drug Product and Solutions
Table 65. GW Pharmaceuticals Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Botanical Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Botanical Drug Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Botanical Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Botanical Drug Players Head Office, Products and Services Provided
Table 70. Botanical Drug Mergers & Acquisitions in the Past Five Years
Table 71. Botanical Drug New Entrants and Expansion Plans
Table 72. Global Botanical Drug Revenue (USD Million) by Type (2017-2022)
Table 73. Global Botanical Drug Revenue Share by Type (2017-2022)
Table 74. Global Botanical Drug Revenue Forecast by Type (2023-2028)
Table 75. Global Botanical Drug Revenue by Application (2017-2022)
Table 76. Global Botanical Drug Revenue Forecast by Application (2023-2028)
Table 77. North America Botanical Drug Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Botanical Drug Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Botanical Drug Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Botanical Drug Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Botanical Drug Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Botanical Drug Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Botanical Drug Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Botanical Drug Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Botanical Drug Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Botanical Drug Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Botanical Drug Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Botanical Drug Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Botanical Drug Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Botanical Drug Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Botanical Drug Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Botanical Drug Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Botanical Drug Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Botanical Drug Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Botanical Drug Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Botanical Drug Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Botanical Drug Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Botanical Drug Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Botanical Drug Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Botanical Drug Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Botanical Drug Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Botanical Drug Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Botanical Drug Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Botanical Drug Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Botanical Drug Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Botanical Drug Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Botanical Drug Picture
Figure 2. Global Botanical Drug Revenue Market Share by Type in 2021
Figure 3. Prescription Drug
Figure 4. OTC
Figure 5. Botanical Drug Revenue Market Share by Application in 2021
Figure 6. Cardiovascular Picture
Figure 7. Tumor Picture
Figure 8. Respiratory System Picture
Figure 9. Others Picture
Figure 10. Global Botanical Drug Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Botanical Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Botanical Drug Revenue Market Share by Region (2017-2028)
Figure 13. Global Botanical Drug Revenue Market Share by Region in 2021
Figure 14. North America Botanical Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Botanical Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Botanical Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Botanical Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Botanical Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Botanical Drug Market Drivers
Figure 20. Botanical Drug Market Restraints
Figure 21. Botanical Drug Market Trends
Figure 22. Buchang Pharmaceuticals Recent Developments and Future Plans
Figure 23. China TCM Recent Developments and Future Plans
Figure 24. Tsumura Recent Developments and Future Plans
Figure 25. Schwabe Recent Developments and Future Plans
Figure 26. Tong Ren Tang Recent Developments and Future Plans
Figure 27. Jumpcan Pharmaceutical Recent Developments and Future Plans
Figure 28. Guangzhou Baiyunshan Pharmaceutical Recent Developments and Future Plans
Figure 29. Yunnan Baiyao Recent Developments and Future Plans
Figure 30. Tasly Holding Group Recent Developments and Future Plans
Figure 31. Bionorica Se Recent Developments and Future Plans
Figure 32. Huarun 999 Recent Developments and Future Plans
Figure 33. Taiji Recent Developments and Future Plans
Figure 34. Weleda Recent Developments and Future Plans
Figure 35. Kwangdong Recent Developments and Future Plans
Figure 36. GW Pharmaceuticals Recent Developments and Future Plans
Figure 37. Global Botanical Drug Revenue Share by Players in 2021
Figure 38. Botanical Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Botanical Drug Revenue Market Share in 2021
Figure 40. Global Top 10 Players Botanical Drug Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Botanical Drug Revenue Share by Type in 2021
Figure 43. Global Botanical Drug Market Share Forecast by Type (2023-2028)
Figure 44. Global Botanical Drug Revenue Share by Application in 2021
Figure 45. Global Botanical Drug Market Share Forecast by Application (2023-2028)
Figure 46. North America Botanical Drug Sales Market Share by Type (2017-2028)
Figure 47. North America Botanical Drug Sales Market Share by Application (2017-2028)
Figure 48. North America Botanical Drug Revenue Market Share by Country (2017-2028)
Figure 49. United States Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Botanical Drug Sales Market Share by Type (2017-2028)
Figure 53. Europe Botanical Drug Sales Market Share by Application (2017-2028)
Figure 54. Europe Botanical Drug Revenue Market Share by Country (2017-2028)
Figure 55. Germany Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Botanical Drug Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Botanical Drug Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Botanical Drug Revenue Market Share by Region (2017-2028)
Figure 63. China Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Botanical Drug Sales Market Share by Type (2017-2028)
Figure 70. South America Botanical Drug Sales Market Share by Application (2017-2028)
Figure 71. South America Botanical Drug Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Botanical Drug Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Botanical Drug Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Botanical Drug Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Botanical Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
